These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 15696148)
1. Shortening the treatment of tuberculosis. Mitchison DA Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148 [No Abstract] [Full Text] [Related]
2. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Andries K; Verhasselt P; Guillemont J; Göhlmann HW; Neefs JM; Winkler H; Van Gestel J; Timmerman P; Zhu M; Lee E; Williams P; de Chaffoy D; Huitric E; Hoffner S; Cambau E; Truffot-Pernot C; Lounis N; Jarlier V Science; 2005 Jan; 307(5707):223-7. PubMed ID: 15591164 [TBL] [Abstract][Full Text] [Related]
3. Microbiology. TB--a new target, a new drug. Cole ST; Alzari PM Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490 [No Abstract] [Full Text] [Related]
7. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. Gumbo T; Louie A; Deziel MR; Parsons LM; Salfinger M; Drusano GL J Infect Dis; 2004 Nov; 190(9):1642-51. PubMed ID: 15478070 [TBL] [Abstract][Full Text] [Related]
8. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
9. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. Diacon AH; Pym A; Grobusch M; Patientia R; Rustomjee R; Page-Shipp L; Pistorius C; Krause R; Bogoshi M; Churchyard G; Venter A; Allen J; Palomino JC; De Marez T; van Heeswijk RP; Lounis N; Meyvisch P; Verbeeck J; Parys W; de Beule K; Andries K; Mc Neeley DF N Engl J Med; 2009 Jun; 360(23):2397-405. PubMed ID: 19494215 [TBL] [Abstract][Full Text] [Related]
11. Trench warfare in a battle with TB. Marshall E Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790 [No Abstract] [Full Text] [Related]
12. Ring-substituted quinolines as potential anti-tuberculosis agents. Vangapandu S; Jain M; Jain R; Kaur S; Singh PP Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831 [TBL] [Abstract][Full Text] [Related]
13. New generation methods for drug susceptibility testing for tuberculosis. Katoch VM Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820 [No Abstract] [Full Text] [Related]
14. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207. Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841 [TBL] [Abstract][Full Text] [Related]
15. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM; Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911 [No Abstract] [Full Text] [Related]
17. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories. Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070 [TBL] [Abstract][Full Text] [Related]
19. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia. Massi MN; Wahyuni S; Halik H; ; Yusuf I; Leong FJ; Dick T; Phyu S Int J Tuberc Lung Dis; 2011 Apr; 15(4):489-95. PubMed ID: 21396208 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids. Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]